Marvin Yingbin Ouyang, Ph.D., vice president of technology at Cyagen Biosciences, Inc., will present “CRISPR/Cas9 and TurboKnockout: Technologies for rapid generation of knockout/knockin mouse models,” sponsored by Cyagen Biosciences.

Tuesday, July 12
noon to 1 p.m.
OHSU Auditorium
Marquam Hill

Dr. Ouyang will review the traditional model of pronuclear injection based transgenics and ES cell homologous recombination based gene targeting, and go over the recently developed CRISPR-mediated genome editing technology, with an emphasis on the pros and cons of each technology and their applications. He will introduce TurboKnockout, the newest ES-cell based gene targeting technology which allows the generation of conditional knockout/knockin mouse models in as fast as six months. This presentation will also highlight VectorBuilder, a novel online tool which promises to revolutionize the way DNA vector cloning is done.